Michael I Leff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael I Leff

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

The Journal of Biological Chemistry|April 14, 2019

Weaponizing T-cell receptors through molecular engineeringElissa K Leonard, Michael I Leff, Jamie B Spangler

Biorxiv : the Preprint Server for Biology|May 19, 2023

Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.

JCI Insight|August 8, 2024

Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

The Journal of Biological Chemistry|April 14, 2019

Weaponizing T-cell receptors through molecular engineeringElissa K Leonard, Michael I Leff, Jamie B Spangler

Biorxiv : the Preprint Server for Biology|May 19, 2023

Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.

JCI Insight|August 8, 2024

Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.

Pageof 1